Medline Statistics
Total Valuation
Medline has a market cap or net worth of $55.45 billion. The enterprise value is $64.48 billion.
| Market Cap | 55.45B |
| Enterprise Value | 64.48B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Medline has 1.32 billion shares outstanding. The number of shares has decreased by -94.97% in one year.
| Current Share Class | 878.66M |
| Shares Outstanding | 1.32B |
| Shares Change (YoY) | -94.97% |
| Shares Change (QoQ) | +52.91% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 60.78% |
| Float | 382.03M |
Valuation Ratios
The trailing PE ratio is 64.67 and the forward PE ratio is 27.93. Medline's PEG ratio is 4.40.
| PE Ratio | 64.67 |
| Forward PE | 27.93 |
| PS Ratio | 1.81 |
| Forward PS | 1.67 |
| PB Ratio | 3.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.50 |
| P/OCF Ratio | 23.29 |
| PEG Ratio | 4.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.92, with an EV/FCF ratio of 34.30.
| EV / Earnings | 112.53 |
| EV / Sales | 2.10 |
| EV / EBITDA | 23.92 |
| EV / EBIT | 38.70 |
| EV / FCF | 34.30 |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.65.
| Current Ratio | 4.04 |
| Quick Ratio | 2.37 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 4.45 |
| Debt / FCF | 6.73 |
| Interest Coverage | 2.39 |
Financial Efficiency
Return on equity (ROE) is 4.85% and return on invested capital (ROIC) is 4.55%.
| Return on Equity (ROE) | 4.85% |
| Return on Assets (ROA) | 2.70% |
| Return on Invested Capital (ROIC) | 4.55% |
| Return on Capital Employed (ROCE) | 4.50% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $681,778 |
| Profits Per Employee | $12,733 |
| Employee Count | 45,000 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 4.85 |
Taxes
In the past 12 months, Medline has paid $242.00 million in taxes.
| Income Tax | 242.00M |
| Effective Tax Rate | 21.65% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 35.15 |
| 200-Day Moving Average | 39.42 |
| Relative Strength Index (RSI) | 75.19 |
| Average Volume (20 Days) | 10,790,043 |
Short Selling Information
The latest short interest is 37.84 million, so 2.88% of the outstanding shares have been sold short.
| Short Interest | 37.84M |
| Short Previous Month | 40.82M |
| Short % of Shares Out | 2.88% |
| Short % of Float | 9.91% |
| Short Ratio (days to cover) | 4.51 |
Income Statement
In the last 12 months, Medline had revenue of $30.68 billion and earned $573.00 million in profits. Earnings per share was $0.65.
| Revenue | 30.68B |
| Gross Profit | 7.49B |
| Operating Income | 1.67B |
| Pretax Income | 1.12B |
| Net Income | 573.00M |
| EBITDA | 2.70B |
| EBIT | 1.67B |
| Earnings Per Share (EPS) | $0.65 |
Balance Sheet
The company has $3.62 billion in cash and $12.65 billion in debt, with a net cash position of -$9.03 billion or -$6.86 per share.
| Cash & Cash Equivalents | 3.62B |
| Total Debt | 12.65B |
| Net Cash | -9.03B |
| Net Cash Per Share | -$6.86 |
| Equity (Book Value) | 19.39B |
| Book Value Per Share | 13.43 |
| Working Capital | 9.52B |
Cash Flow
In the last 12 months, operating cash flow was $2.38 billion and capital expenditures -$501.00 million, giving a free cash flow of $1.88 billion.
| Operating Cash Flow | 2.38B |
| Capital Expenditures | -501.00M |
| Depreciation & Amortization | 1.03B |
| Net Borrowing | -4.09B |
| Free Cash Flow | 1.88B |
| FCF Per Share | $1.43 |
Margins
Gross margin is 24.42%, with operating and profit margins of 5.43% and 1.84%.
| Gross Margin | 24.42% |
| Operating Margin | 5.43% |
| Pretax Margin | 3.64% |
| Profit Margin | 1.84% |
| EBITDA Margin | 8.79% |
| EBIT Margin | 5.43% |
| FCF Margin | 6.13% |
Dividends & Yields
Medline does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 94.97% |
| Shareholder Yield | 94.97% |
| Earnings Yield | 1.55% |
| FCF Yield | 3.39% |
Analyst Forecast
The average price target for Medline is $45.35, which is 7.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $45.35 |
| Price Target Difference | 7.57% |
| Analyst Consensus | Buy |
| Analyst Count | 27 |
| Revenue Growth Forecast (3Y) | 8.76% |
| EPS Growth Forecast (3Y) | 10.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medline has an Altman Z-Score of 2.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.18 |
| Piotroski F-Score | 6 |